This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EVM | Ann: Appendix 4C & Appendix 4D reports update. | 28/03/19 | 3 | 1.2K | |||
|
|||||||
EVM | Ann: Results of Meeting | 06/02/19 | 2 | 789 | |||
|
|||||||
EVM | Ann: Chairman's Address to Shareholders | 31/01/19 | 1 | 481 | |||
|
|||||||
EVM | Ann: Rereleased Notice of Meeting & Proxy form clarification | 29/01/19 | 5 | 1.5K | |||
|
|||||||
EVM | Ann: Amendment to Notice of Meeting & Proxy form | 11/01/19 | 3 | 521 | |||
|
|||||||
EVM | Ann: Notice of Annual General Meeting/Proxy Form | 10/01/19 | 3 | 1.0K | |||
|
|||||||
EVM | Ann: Annual Report to shareholders | 23/12/18 | 6 | 1.7K | |||
|
|||||||
EVM | Ann: Initial Directors Interest Notice | 12/12/18 | 1 | 435 | |||
|
See All Discussions